Cancer doesn’t discriminate, but access to great skin cancer care hasn’t always been the same for everyone. At Providence, we are deeply committed to making sure every patient we treat has access to the best cancer care. We offer various location-specific services to help our patients receive equitable care, such as translation for non-English-speaking patients, telehealth and transportation assistance. We value, respect and support the racial, ethnic, religious, spiritual, gender and sexual identities of each member of our diverse communities, and we welcome all patients, regardless of their ability to pay. We aim to make sure every patient is treated equally and with dignity – whoever you are, and wherever you're at.

As a patient at Providence, you have access to the largest community-based cancer network in the United States. Being part of a collaborative network means that your local skin cancer care team shares knowledge and experience with other world-class clinicians across 51 hospitals in seven states. The extent and power of our network is one of the reasons more than 2,400 new melanoma patients, and over 50,000 new cancer patients, trust Providence each year.

Providence is well-known for offering options – and hope – to patients seeking the most advanced procedures and therapies to treat skin cancer. We led the global clinical trial of the first immunotherapy medicine approved for patients with melanoma, which was the first to improve patient survival rates. We collaborate with researchers across the country to advance state-of-the-art treatments for skin cancers. As a patient, you have the opportunity to participate in one of over 45 clinical trials happening across the Providence network for advanced skin cancer treatment, such as a clinical trial exploring vaccines for patients experiencing the earlier stages of melanoma.